Lentocilin Injection, Powder, For Suspension
Product Images NDC 84383-110

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lentocilin (NDC 84383-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Laborat�rios Atral, S.a., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-vial (Carton Vial)

FDA Label Image

Indications&usage Section (Picture 1)

Indications&usage Section (Picture 1)
This text contains information about Lentocilin S, a medication containing benzathine benzylpenicillin, an antibiotic used to treat various infections in adults and children. It provides details on the dosage, administration, possible side effects, and precautions to be taken before using the medicine. Lentocilin S is indicated for conditions such as upper respiratory tract infections, syphilis, yaws, bejel, rheumatic fever, and diphtheria prevention. The text advises consulting a healthcare professional for proper usage and monitoring for potential side effects like allergic reactions and inflammation of the large intestine. Additional guidance is given for pregnant or breastfeeding individuals and the use of Lentocilin S in newborns and children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.